Gene therapy using bacterial vectors

被引:12
作者
Celec, Peter [1 ,2 ,3 ,4 ]
Gardlik, Roman [1 ,2 ]
机构
[1] Comenius Univ, Fac Med, Inst Mol Biomedicine, Sasinkova 4, Bratislava 81108, Slovakia
[2] Slovak Acad Sci, Biomed Res Ctr, Inst Clin & Translat Med, Bratislava, Slovakia
[3] Comenius Univ, Fac Med, Inst Pathophysiol, Bratislava, Slovakia
[4] Comenius Univ, Fac Nat Sci, Dept Mol Biol, Bratislava, Slovakia
来源
FRONTIERS IN BIOSCIENCE-LANDMARK | 2017年 / 22卷
关键词
Bactofection; Alternative Gene Therapy; Transgene Expression; DNA vaccination; Review; ATTENUATED SALMONELLA-TYPHIMURIUM; EUKARYOTIC EXPRESSION PLASMIDS; ENTERICA SEROVAR TYPHIMURIUM; MODIFIED LACTOCOCCUS-LACTIS; INFLAMMATORY-BOWEL-DISEASE; DNA-MEDIATED IMMUNIZATION; ENDOTHELIAL GROWTH-FACTOR; MAMMALIAN HOST-CELLS; IN-VIVO; ESCHERICHIA-COLI;
D O I
10.2741/4473
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bacteria can be used for gene therapy via two strategies - either by transfection of eukaryotic host cells using bacteria - bactofection or by alternative gene therapy that does not alter the host genome, but uses the prokaryotic expression system that can be controlled or stopped from outside. While bactofection is optimal for gene substitution and DNA vaccination, alternative gene therapy is suitable for in situ delivery of proteins and treatment with intracellular bactochondria. A specific form of bacteria-mediated gene therapy is the transkingdom RNA interference. In this review advantages and issues related to bacterial vectors as well as the major applications in biomedical research are summarized. Despite numerous published experiments, especially in the treatment of solid tumors and gut infections, the progress in the clinics lags behind and major improvements in the safety and even more in the efficiency of these approaches are needed.
引用
收藏
页码:81 / 95
页数:15
相关论文
共 100 条
  • [1] Ada Gordon, 2003, Expert Opin Emerg Drugs, V8, P27, DOI 10.1517/eoed.8.1.27.21025
  • [2] Vectorology recapitulates virology - will it capitulate oncology?
    Aguilar-Cordova, E
    [J]. NATURE BIOTECHNOLOGY, 2003, 21 (07) : 756 - 757
  • [3] Induction of Effective Antitumor Response After Mucosal Bacterial Vector Mediated DNA Vaccination With Endogenous Prostate Cancer Specific Antigen
    Ahmad, Sarfraz
    Casey, Garrett
    Cronin, Michelle
    Rajendran, Simon
    Sweeney, Paul
    Tangney, Mark
    O'Sullivan, Gerald C.
    [J]. JOURNAL OF UROLOGY, 2011, 186 (02) : 687 - 693
  • [4] Genetically modified probiotics in foods
    Ahmed, FE
    [J]. TRENDS IN BIOTECHNOLOGY, 2003, 21 (11) : 491 - 497
  • [5] Sex Differences in Experimentally Induced Colitis in Mice: a Role for Estrogens
    Babickova, Janka
    Tothova, L'ubomira
    Lengyelova, Eva
    Bartonova, Anastazie
    Hodosy, Julius
    Gardlik, Roman
    Celec, Peter
    [J]. INFLAMMATION, 2015, 38 (05) : 1996 - 2006
  • [6] A phase I trial with Transgenic bacteria expressing interleukin-10 in Crohn's disease
    Braat, Henri
    Rottiers, Pieter
    Hommes, Daniel W.
    Huyghebaert, Nathalie
    Remaut, Erik
    Remon, Jean-Paul
    Van Deventer, Sander J. H.
    Neirynck, Sabine
    Peppelenbosch, Maikel P.
    Steidler, Lothar
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2006, 4 (06) : 754 - 759
  • [7] AG013, a mouth rinse formulation of Lactococcus lactis secreting human Trefoil Factor 1, provides a safe and efficacious therapeutic tool for treating oral mucositis
    Caluwaerts, Silvia
    Vandenbroucke, Klaas
    Steidler, Lothar
    Neirynck, Sabine
    Vanhoenacker, Peter
    Corveleyn, Sam
    Watkins, Brynmor
    Sonis, Stephen
    Coulie, Bernard
    Rottiers, Pieter
    [J]. ORAL ONCOLOGY, 2010, 46 (07) : 564 - 570
  • [8] The use of transformed Escherichia coli for experimental angiogenesis induced by regulated in situ production of vascular endothelial growth factor -: an alternative gene therapy
    Celec, P
    Gardlík, R
    Pálffy, R
    Hodosy, A
    Stuchlík, S
    Drahovská, H
    Stuchlíková, M
    Minárik, G
    Lukács, J
    Jurkovicová, I
    Hulín, I
    Turna, J
    Jakubovsky, J
    Kopáni, M
    Danisovic, L
    Jandzík, D
    Kúdela, M
    Yonemitsu, Y
    [J]. MEDICAL HYPOTHESES, 2005, 64 (03) : 505 - 511
  • [9] Vascular endothelial growth factor targeted RNA interference as a modulator of angiogenesis
    Celec, Peter
    Yonemitsu, Yoshikazu
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2008, 62 (06) : 349 - 351
  • [10] Incorporation of therapeutically modified bacteria into gut microbiota inhibits obesity
    Chen, Zhongyi
    Guo, Lilu
    Zhang, Yongqin
    Walzem, Rosemary L.
    Pendergast, Julie S.
    Printz, Richard L.
    Morris, Lindsey C.
    Matafonova, Elena
    Stien, Xavier
    Kang, Li
    Coulon, Denis
    McGuinness, Owen P.
    Niswender, Kevin D.
    Davies, Sean S.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2014, 124 (08) : 3391 - 3406